FORMULASI DAN EVALUASI SOLID LIPID NANOPARTICLES (SLN) RIFABUTIN
Rifabutin (RFB) is very potential for tuberculosis clinical treatment. However RFB has only 20% of bioavailability and is categorized as BCS class II. Formulation of Solid Lipid Nanopaticles (SLN) is an alternative to overcome the low bioavailability of RFB. This study aims to formulate RFB into S...
Saved in:
| Main Author: | |
|---|---|
| Format: | Final Project |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/44278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |